AMICUS THERAPEUTICS, INC. Assets, Fair Value Disclosure
AMICUS THERAPEUTICS, INC. had Assets, Fair Value Disclosure of $75.32 million as of 2025-09-30, per its 10-Q filed 2025-11-04.
Financial Statements › Notes › Fair Value Disclosures › Fair Value, Net Asset (Liability)
us-gaap:AssetsFairValueDisclosure · last filed 2025-11-04
- 2025-09-30: Assets, Fair Value Disclosure $75.32M.
- 2025-06-30: Assets, Fair Value Disclosure $74.42M.
- 2025-03-31: Assets, Fair Value Disclosure $70.92M.
- 2024-12-31: Assets, Fair Value Disclosure $38.36M.
| Period end | Assets, Fair Value Disclosure | Assets, Fair Value Disclosure as first filed |
|---|---|---|
| 2025-09-30 | $75.32M 10-Q · filed 2025-11-04 | |
| 2025-06-30 | $74.42M 10-Q · filed 2025-07-31 | |
| 2025-03-31 | $70.92M 10-Q · filed 2025-05-01 | |
| 2024-12-31 | $38.36M 10-Q · filed 2025-11-04 | |
| 2024-09-30 | $23.88M 10-Q · filed 2024-11-06 | |
| 2024-06-30 | $58.02M 10-Q · filed 2024-08-08 | |
| 2024-03-31 | $36.89M 10-Q · filed 2024-05-09 | |
| 2023-12-31 | $46.69M 10-K · filed 2025-02-19 | |
| 2023-09-30 | $23.65M 10-Q · filed 2023-11-08 | |
| 2023-06-30 | $61.05M 10-Q · filed 2023-08-08 | |
| 2023-03-31 | $112.74M 10-Q · filed 2023-05-10 | |
| 2022-12-31 | $150.19M 10-K · filed 2024-02-28 | |
| 2022-09-30 | $82.06M 10-Q · filed 2022-11-07 | |
| 2022-06-30 | $156.16M 10-Q · filed 2022-08-04 | |
| 2022-03-31 | $183.23M 10-Q · filed 2022-05-10 | |
| 2021-12-31 | $242.05M 10-K · filed 2023-03-01 | |
| 2021-09-30 | $175.42M 10-Q · filed 2021-11-09 | |
| 2021-06-30 | $210.71M 10-Q · filed 2021-08-05 | |
| 2021-03-31 | $236.49M 10-Q · filed 2021-05-10 | |
| 2020-12-31 | $324.06M 10-K · filed 2022-02-24 | |
| 2020-09-30 | $301.96M 10-Q · filed 2020-11-05 | |
| 2020-06-30 | $148.25M 10-Q · filed 2020-08-10 | |
| 2020-03-31 | $218.62M 10-Q · filed 2020-05-07 | |
| 2019-12-31 | $314.27M 10-K · filed 2021-03-01 | |
| 2019-09-30 | $351.80M 10-Q · filed 2019-11-12 | |
| 2019-06-30 | $358.90M 10-Q · filed 2019-08-08 | |
| 2019-03-31 | $345.54M 10-Q · filed 2019-05-09 | |
| 2018-12-31 | $427.08M 10-K · filed 2020-03-02 | |
| 2018-09-30 | $365.49M 10-Q · filed 2018-11-05 | |
| 2018-06-30 | $482.16M 10-Q · filed 2018-08-07 | |
| 2018-03-31 | $482.89M 10-Q · filed 2018-05-09 | |
| 2017-12-31 | $311.70M 10-K · filed 2019-02-28 | |
| 2017-09-30 | $364.56M 10-Q · filed 2017-11-08 | |
| 2017-06-30 | $191.76M 10-Q · filed 2017-08-07 | |
| 2017-03-31 | $236.88M 10-Q · filed 2017-05-09 | |
| 2016-12-31 | $144.75M 10-K · filed 2018-03-01 | |
| 2016-09-30 | $213.72M 10-Q · filed 2016-11-07 | |
| 2016-06-30 | $215.35M 10-Q · filed 2016-08-09 | |
| 2016-03-31 | $166.89M 10-Q · filed 2016-05-03 | |
| 2015-12-31 | $145.21M 10-K/A · filed 2017-03-03 | $214.69M 10-Q · filed 2016-05-03 |
| 2015-09-30 | $252.47M 10-Q · filed 2015-11-04 | |
| 2014-12-31 | $169.14M 10-Q · filed 2015-11-04 |